CVE:CRM - CRH Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$119.26 -2.14 (-1.76 %)
(As of 05/22/2018 11:31 AM ET)
Previous CloseC$121.40
Today's RangeC$118.81 - C$121.94
52-Week RangeC$83.00 - C$128.87
Volume1.67 million shs
Average Volume5.83 million shs
Market CapitalizationC$31.20 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63

About CRH Medical (CVE:CRM)

CRH Medical logoCRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.

Receive CRM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:CRM
CUSIPN/A
Phone+1-604-6331440

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares722,300,000

CRH Medical (CVE:CRM) Frequently Asked Questions

What is CRH Medical's stock symbol?

CRH Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CRM."

Who are CRH Medical's key executives?

CRH Medical's management team includes the folowing people:
  • Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
  • Edward J. Wright, Chief Executive Officer, Director
  • Richard K. Bear, Chief Financial Officer (Age 48)
  • Jay Kreger, President of CRH Anesthesia Management
  • David Johnson, Independent Director
  • Bergein F. Overholt M.D., Independent Director
  • Todd R. Patrick, Independent Director (Age 48)
  • Ian A. Webb, Independent Director (Age 61)

Has CRH Medical been receiving favorable news coverage?

Media headlines about CRM stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CRH Medical earned a daily sentiment score of 0.18 on Accern's scale. They also gave news headlines about the company an impact score of 45.49 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of CRH Medical?

Shares of CRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRM stock can currently be purchased for approximately C$119.26.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of C$31.20 million.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


MarketBeat Community Rating for CRH Medical (CRM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  76 (Vote Outperform)
Underperform Votes:  61 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about CRH Medical and other stocks. Vote "Outperform" if you believe CRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

CRH Medical (CVE:CRM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for CRH Medical in the last 12 months. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

CRH Medical (CVE:CRM) Consensus Price Target History

Price Target History for CRH Medical (CVE:CRM)

CRH Medical (CVE:CRM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
7/17/2017CIBCDowngradeSector Outperform ➝ Sector PerformView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Dividends

CRH Medical (CVE:CRM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

CRH Medical (CVE CRM) Insider Trading and Institutional Ownership History

Insider Trading History for CRH Medical (CVE:CRM)

CRH Medical (CVE CRM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

CRH Medical (CVE CRM) News Headlines

Source:
DateHeadline
Promising responses seen with Agios leukemia drug in studyPromising responses seen with Agios leukemia drug in study
www.reuters.com - December 11 at 6:03 PM
CRH Medical beats on revenueCRH Medical beats on revenue
seekingalpha.com - November 1 at 11:28 PM
Boston Scientifics (BSX) Q3 Earnings In Line, Guidance UpBoston Scientific's (BSX) Q3 Earnings In Line, Guidance Up
finance.yahoo.com - October 26 at 7:52 PM
These 3 stocks are smart bets on the artificial intelligence revolutionThese 3 stocks are smart bets on the artificial intelligence revolution
www.marketwatch.com - October 20 at 4:07 AM
Omnicom Groups (OMC) CEO John Wren on Q3 2017 Results - Earnings Call TranscriptOmnicom Group's (OMC) CEO John Wren on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 17 at 6:19 PM
Is CRH Medical (CRHM) a Suitable Pick for Value Investors?Is CRH Medical (CRHM) a Suitable Pick for Value Investors?
www.zacks.com - October 3 at 5:21 PM
CRH Medical Corporation Announces the Purchase of Anesthesia Practice in San AntonioCRH Medical Corporation Announces the Purchase of Anesthesia Practice in San Antonio
finance.yahoo.com - September 28 at 5:20 PM
CRH sees lower Q3 revenues due to Hurricane Irma; shares down 4%CRH sees lower Q3 revenues due to Hurricane Irma; shares down 4%
seekingalpha.com - September 23 at 2:34 AM
CRH Medical Corp (CVE:CRM) Cut to Sector Perform at CIBCCRH Medical Corp (CVE:CRM) Cut to Sector Perform at CIBC
www.americanbankingnews.com - July 17 at 1:54 PM

SEC Filings

CRH Medical (CVE:CRM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

CRH Medical (CVE CRM) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.